Jainil Shah's questions to Dr Reddy's Laboratories Ltd (RDY) leadership • Q1 2025
Question
Jainil Shah of JM Financial asked for clarification on the Nicotine Replacement Therapy (NRT) acquisition, specifically why the gross assets were reported as high as GBP 413 million and whether a large portion of this would be goodwill.
Answer
CEO Erez Israeli stated he had not seen the seller's balance sheet but assumed the high value was mostly related to intangible assets.